Profil
Dr. Allen Ebens is a Director & Chief Scientific Officer at Virsti Therapeutics, Inc. and an Executive Vice President-Research at Vera Therapeutics, Inc. He is on the Board of Directors at Prescient Therapeutics Ltd. and Virsti Therapeutics, Inc. Dr. Ebens was previously employed as a Senior Director-Immune Oncology by NGM Biopharmaceuticals, Inc. He received his doctorate degree from the University of California, Los Angeles.
Aktive Positionen von Allen Ebens
| Unternehmen | Position | Beginn |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 01.06.2020 |
| VERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2024 |
Virsti Therapeutics, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Allen Ebens
| Unternehmen | Position | Ende |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2018 |
Ausbildung von Allen Ebens
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Prescient Therapeutics Ltd.
Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Virsti Therapeutics, Inc. |
















